Cyclin D1-Cdk4 controls glucose metabolism independently of cell cycle progression
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Insulin constitutes a principal evolutionarily conserved hormonal axis for maintaining glucose homeostasis; dysregulation of this axis causes diabetes. PGC-1α (peroxisome-proliferator-activated receptor-γ coactivator-1α) links insulin signalling to the expression of glucose and lipid metabolic genes. The histone acetyltransferase GCN5 (general control non-repressed protein 5) acetylates PGC-1α and suppresses its transcriptional activity, whereas sirtuin 1 deacetylates and activates PGC-1α. Although insulin is a mitogenic signal in proliferative cells, whether components of the cell cycle machinery contribute to its metabolic action is poorly understood. Here we report that in mice insulin activates cyclin D1-cyclin-dependent kinase 4 (Cdk4), which, in turn, increases GCN5 acetyltransferase activity and suppresses hepatic glucose production independently of cell cycle progression. Through a cell-based high-throughput chemical screen, we identify a Cdk4 inhibitor that potently decreases PGC-1α acetylation. Insulin/GSK-3β (glycogen synthase kinase 3-beta) signalling induces cyclin D1 protein stability by sequestering cyclin D1 in the nucleus. In parallel, dietary amino acids increase hepatic cyclin D1 messenger RNA transcripts. Activated cyclin D1-Cdk4 kinase phosphorylates and activates GCN5, which then acetylates and inhibits PGC-1α activity on gluconeogenic genes. Loss of hepatic cyclin D1 results in increased gluconeogenesis and hyperglycaemia. In diabetic models, cyclin D1-Cdk4 is chronically elevated and refractory to fasting/feeding transitions; nevertheless further activation of this kinase normalizes glycaemia. Our findings show that insulin uses components of the cell cycle machinery in post-mitotic cells to control glucose homeostasis independently of cell division.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, CDK4 phosphorylation of GCN5 can lead to acetylation of PGC-1α and is associated with decreased glucose metabolism in hepatic cells (Lee et al., 2014).”
From CDK4/6 Inhibitors: The Mechanism of Action May Not Be as Simple as Once Thought (2018) · cites this paper as Lee et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cell cycle, CDKs and cancer: a changing paradigm
Malumbres, M., & Barbacid, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2602 · Cited by 3,957 · cited 1×
“CDK4 regulates G1 to S phase transition and its kinase activity is dependent on its binding to one of the three D-type cyclins including cyclin D1 13 .”
BackgroundNutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
Self-citationReplication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes
Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., Timpson, N. J., Perry, J. R. B., Rayner, N. W., Freathy, R. M., et al. (2007) · Science · doi:10.1126/science.1142364 · Cited by 2,194 · cited 1×
“Interestingly, genome-wide association studies have revealed that mutations of CDKN2A, a CDK4 inhibitor, are significantly correlated with a high risk of type 2 diabetes 27 .”
BackgroundGlycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130 · cited 1×
“GSK3 β , active during fasting and inactive during refeeding due to its phosphorylation by insulin-AKT signaling, negatively regulates cyclin D1 through phosphorylation of T286, causing nuclear exclusion of cyclin D1 and proteasomal degradation 19,22 .”
BackgroundCho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Self-citationInsulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., et al. (2003) · Nature · doi:10.1038/nature01667 · Cited by 1,487
Self-citation(1993) · Genes & Development · doi:10.1101/gad.7.3.331 · Cited by 1,264
Fry, D. W., Harvey, P. J., Keller, P. R., Elliott, W. L., Meade, M., Trachet, E., Albassam, M., Zheng, X., Leopold, W. R., Pryer, N. K., et al. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1427.3.11 · Cited by 1,236 · cited 1×
“PD 0332991, the most specific CDK4 inhibitor available 15 , led to a similar decrease of PGC-1 α acetylation (Fig.”
BackgroundMatsushime, H., Ewen, M. E., Strom, D. K., Kato, J.-Y., Hanks, S. K., Roussel, M. F., & Sherr, C. J. (1992) · Cell · doi:10.1016/0092-8674(92)90360-o · Cited by 897
Diehl, J. A., Zindy, F., & Sherr, C. J. (1997) · Genes & Development · doi:10.1101/gad.11.8.957 · Cited by 746 · cited 2×
“…of CKD4 activity by cyclin D1 wild-type overepxression or Cyclin D1 T286A mutant, a hyperactive mutant allele spared from proteasomal degradation 19 , but not cyclin D1 K112E (a mutant that cannot activate CDK4 kinase activity 18 ), suppressed gluconeogenic genes and glucose production,…”
Background
Cited by
Items 201–254 of 254
Fan, B., Teng, H., Patrice, Z., Wang, X., Shi, M., Zhao, Y., Zhang, W., Zhao, Y., He, Z.-M., Zong, Y., et al. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106621 · Cited by 2
Period control of the coupled clock and cell cycle systems
Almeida, S., Chaves, M., & Delaunay, F. (2019) · International Conference Computational Systems-Biology and Bioinformatics · doi:10.1145/3365953.3365956 · Cited by 1
Coomar, S., Gasser, J. A., Slabicki, M. M., Donovan, K. A., Fischer, E. S., Ebert, B. L., Gillingham, D. G., & Thomä, N. H. (2025) · RSC Medicinal Chemistry · doi:10.1039/d5md00054h · Cited by 1
Energy Metabolism and Epigenetics
Bultman, S. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-31143-2_87-1 · Cited by 1
Cyclin D1 regulates the hepatic response to feeding: Evidence for non-cell cycle roles in the liverPreprint
Wu, H., Hauser, J. I., Yang, N., Timchenko, N., Klaers, M., Salekeen, R., Manivel, J. C., Abrahante, J. E., Laux, L., Yousefzadeh, M. J., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.25.727739 · Cited by 1
MicroRNAs modify relationships between hemoglobin A1c and race and ethnicity
STROEBEL, B. M., Aouizerat, B. E., Longoria, K. D., Gadgil, M. D., & Flowers, E. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113165 · Cited by 1
Roney, M., & Aluwi, M. F. F. M. (2025) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2025.100004 · Cited by 1
Poon, L. Y., Hsu, L. M., Lam, L. K., Huang, X., Xu, P., Liang, Q., Xie, P., & Yang, S. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1648831 · Cited by 1
Huang, L., Wang, R., Zhou, F., Gao, R., Fan, X., & Miao, Y. (2026) · Animal Bioscience · doi:10.5713/ab.250642 · Cited by 1
Role of the tumour suppressor pathway p53‐p21 in the regulation of metabolism
Pulice, G. (2014) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) · Cited by 1
Levasseur, E. M. (2017) · IUScholarWorks (Indiana University) · doi:10.7912/c2qm05
Wang, C., Han, H., Li, K., Zhang, L., Shu, C., Cao, L., Zhang, M., Yang, Y., Liu, S., Shi, H., et al. (2026) · Circulation · doi:10.1161/circulationaha.126.079966
CDK-4 regulates nucleolar size and metabolism at the cost of late-life fitness in C. elegans
Webster, R., Quintana, M., Yu, B., Fluke, S., Kafri, R., & Derry, W. B. (2025) · Heredity · doi:10.1038/s41437-025-00769-7
Kasraian, Z. (2018) · theses.fr (ABES) · doi:10.70675/a1868dd1z7486z4a30z9abbz9078cd2b51e3
Cold-induced liver dysfunction drives cardiac damage through a liver–heart axis
Feng, J., Zhao, T., Yao, L. L., Tang, H., Zhang, C., Hao, Y., Sun, X., Kachanov, D., Dinislam, K., Liu, X., et al. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178955
Energy Metabolism and Epigenetics
Bultman, S. J. (2019) · Springer eBooks · doi:10.1007/978-3-319-55530-0_87
Stamateris, R. E. (2021) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/padg-ny31
Alzaïd, F., Jakobsson, T., Treuter, E., & Venteclef, N. (2017) · Springer eBooks · doi:10.1007/978-3-319-31143-2_116-1
Alzaïd, F., Jakobsson, T., Treuter, E., & Venteclef, N. (2019) · Springer eBooks · doi:10.1007/978-3-319-55530-0_116
Metabolic control of muscle and muscle stem cell function
Zhang, H. (2016) · Infoscience (Ecole Polytechnique Fédérale de Lausanne) · doi:10.5075/epfl-thesis-7169
Portales, A. E. (2020) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/108071
The molecular mechanics of CDK4/6 inhibitors: resistance pathways and combination strategies
Dharavath, A., Mishra, B. B., & Guru, S. K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-44611-5.00002-x
Wu, J., Liu, X., & Wu, G. (2026) · Journal of Holistic Integrative Pharmacy · doi:10.1016/j.jhip.2026.09.001
Kumar, N., Selvaraj, K., Gopalshami, L. K., Baddireddi, R., Thiruvengadam, K., & Lakshmi, B. S. (2025) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2024.0184
Cyclin Y Overexpression Drives a Fatal Metabolic Syndrome via Defective Glucose HomeostasisPreprint
López-Sainz, L. R., Ayala, E., Sánchez-Belmonte, A., Ortega, S., Caleiras, E. J., Zarzuela, E., Isasa, M., Santiveri, C. M., Campos‐Olivas, R., de Cárcer, G., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.15.694124
CDKs: Much More Than Just the Control of Cell Cycle Progression
Escoté, X. (2014) · Journal of Cell Science & Therapy · doi:10.4172/2157-7013.1000170
Rusin, A., Cocchetto, A. M., & Mothersill, C. E. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146535
Andrikopoulos, S. (2014) · Diabetes · doi:10.2337/db14-0857
Smith, L. E., Hagensen, C. E., Tsiamis, V., van Waardenberg, A. J., Mamchaoui, K., Jensen, O. N., Schwämmle, V., & Rogowska-Wrzesińska, A. (2026) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2026.101619
Morzyglod, L. (2015) · theses.fr (ABES) · doi:10.70675/753e089bzb365z4663za465z80005940e75b
Hepatitis C virus-induced reprogramming of glutamine metabolism
Levy, P. L. (2014) · theses.fr (ABES) · doi:10.70675/929a33efz4d38z446cz8ed0z4114fa34d6ea
Yang, C.-H. (2017) · Minerva Access (University of Melbourne)
Interactome de la méthionine synthase et compartimentation de la synthèse de méthionine
Jeandel, M. (2024) · theses.fr (ABES) · doi:10.70675/2814fb49z2484z48eczb297z926225077009
Mechanisms Contributing to Animal Cell Size Homeostasis
Tan, C. E. (2022) · TSpace (University of Toronto)
Deleye, Y. (2018) · theses.fr (ABES) · doi:10.70675/0c2dc8b7zb158z4d3ez9e6fz9d97c222b110
Lysosomes at the crossroads between CDK4 and mTOR pathway
Martínez-Carreres, L. (2019) · IRIS
Etude du rôle de la cycline D1 dans la survie cellulaire
Champagne, J. (2018) · theses.fr (ABES) · doi:10.70675/de0e559cz9817z4f08z9dddz412f9008ddac
Physiopathologie du lymphome à cellules du manteau : de la mécanistique aux modèles précliniques
Body, S. (2017) · theses.fr (ABES) · doi:10.70675/0749fbf1z0342z4b18z85f7zb029455dd09e
MicroRNAs in Pancreatic Ductal Adenocarcinoma: New Approaches For Better Diagnosis And Therapy
Mortoglou, M. (2024) · WestminsterResearch (University of Westminster) · doi:10.34737/w7vw2
Foma, A. M., Ocheje, O. M., Asgari, Y., Malekshahi, Z. V., Faradonbeh, D. R., Raigani, M., Foma, C. A., Kheirandish, M. H., Sokut, F., Davami, F., et al. (2025) · Research Square · doi:10.21203/rs.3.rs-6353635/v1
Tian, M., Hua, Y., Liu, Q., Jin, N., Wu, X., Wang, K., Yan, M., Sun, T., Hao, C., Zhao, Y., et al. (2026) · MedComm – Oncology · doi:10.1002/mog2.70096
Dietary and Cellular Mechanisms Regulating Hepatocyte Proliferation and Cancer
Ploeger, J. M. (2017) · University of Minnesota Digital Conservancy (University of Minnesota)
Ellis, A. A. (2020) · NCSU Libraries Repository (North Carolina State University Libraries)
The Role of Protein Degradation in Cell Size Regulation
Melo-Gavin, C. (2021) · TSpace (University of Toronto)
Díaz, M., Quesada‐López, T., Villarroya, F., López‐Bermejo, A., de Zegher, F., Ibáñez, L., & Casano, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146770
Role of MASTL in mammals: Molecular functions and physiological relevance
Sanz‐Castillo, B. (2017) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
CDK4 as a novel regulator of brown adipose tissue biology
Castillo‐Armengol, J. (2019) · SERVAL (Université de Lausanne)
Ghazaly, M. M. (2016) · Surrey Research Insight Open Access (The University of Surrey)
CDK4 suppresses gluconeogenesis
Minton, K. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3831
Fascaplysinis a promising agent for the creation of new treatments' methods of glial brain tumors
Bryukhovetskiy, I., Zhidkov, M. E., Kudryavtsev, I. V., Polevshikov, A. V., Mischenko, P., Milkina, E., Bryukhovetskiy, A. S., Zaitsev, S., Lyakhova, I., Vikhareva, V. V., et al. (2016) · Genes and Cells · doi:10.23868/gc120581
Metadata
- Authors
- Lee, Y., Dominy, J. E., Choi, Y. J., Jurczak, M., Tolliday, N., Camporez, J. P., Chim, H., Lim, J.-H., Ruan, H.-B., Yang, X., Vazquez, F., Sicinski, P., Shulman, G. I., & Puigserver, P.
- Affiliations
- Harvard University (US)
- Yale University (US)
- Broad Institute (US)
- Corresponding author
- Puigserver, Pere
- ORCID
- Venue
- Nature
- Published
- 2014-05-25
- Volume
- 510
- Issue
- 7506
- Pages
- 547-551
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4076706
- OpenAlex
- W2095720556
- Cited by
- 234
- References
- 36
- Citations by year
- 2026: 10 · 2025: 17 · 2024: 9 · 2023: 16 · 2022: 15 · 2021: 14 · 2020: 29 · 2019: 28 · 2018: 26 · 2017: 25 · 2016: 20 · 2015: 20 · 2014: 5
- FWCI
- 9.56
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health (2r24dk080261-06a1)
- U.S. Public Health Service (R01 069966)
- National Institute of Mental Health (R03 MH092174)
- National Institute on Drug Abuse (R03DA032468)
- National Cancer Institute (R01CA108420, R01CA083688)
- National Institute of Diabetes and Digestive and Kidney Diseases (R24 DK-080261, R24DK080261-06, R01DK089098, R01DK069966, U24DK059635, F32DK083871, DK059635, P30DK034989)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- cyclin D1, CDK4, insulin signaling, glucose metabolism, gluconeogenesis, PGC-1α, GCN5, histone acetylation, hepatic glucose production, glucose homeostasis, GSK3β, amino acids, diabetes mellitus, CDK4 inhibitors, cell cycle machinery, metabolic disorders
- MeSH terms
- Glycogen Synthase Kinase 3 beta, p300-CBP-Associated Factor, Acetylation, Amino Acids, Animals, Cell Cycle, Cell Nucleus, Cells, Cultured, Diabetes Mellitus, Enzyme Activation, Fasting, Gluconeogenesis, Glucose, Homeostasis, Humans, Hyperglycemia, Hyperinsulinism, Insulin, Male, Phosphorylation, RNA, Messenger, Transcription Factors, Transcription, Genetic, Signal Transduction, Gene Deletion, Cyclin D1, Hepatocytes, Glycogen Synthase Kinase 3, Cell Line, Tumor, Cyclin-Dependent Kinase 4, Mice, Histone Acetyltransferases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.